Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highl

Journal Article · · J. Am. Chem. Soc.
DOI:https://doi.org/10.1021/jacs.7b10965· OSTI ID:1847693

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1847693
Journal Information:
J. Am. Chem. Soc., Vol. 140, Issue (6)
Country of Publication:
United States
Language:
ENGLISH

References (54)

Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain November 1974
Electrophysiology of GABAA and GABAB receptor subtypes January 1988
International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function June 2002
Synaptic inhibition and γ-aminobutyric acid in the mammalian central nervous system January 2013
The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders April 2005
GABAA Receptor but Not Muscarinic Receptor Density Was Decreased in the Brain of Patients with Parkinson’s Disease January 1988
Increased .GAMMA.-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. January 1990
Analysis of glutamate decarboxylase in post-mortem brain tissue in Huntington's chorea January 1974
A novel strategy for the treatment of cocaine addiction October 1998
Treatment of refractory complex partial seizures: role of vigabatrin October 2009
A pharmacologic strategy for the treatment of nicotine addiction January 1999
Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine October 1999
Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction January 2004
Treating cocaine addiction: From preclinical to clinical trial experience with ?-vinyl GABA September 2003
Randomized, Double-Blind, Placebo-Controlled Trial of Vigabatrin for the Treatment of Cocaine Dependence in Mexican Parolees November 2009
Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study January 2009
Design, Synthesis, and Biological Activity of a Difluoro-Substituted, Conformationally Rigid Vigabatrin Analogue as a Potent γ-Aminobutyric Acid Aminotransferase Inhibitor November 2003
The 2011 E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances: (1 S ,3 S )-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a GABA Aminotransferase Inactivator and New Treatment for Drug Addiction and Infantile Spasms January 2012
(1 S , 3 S )-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid ( CPP-115 ), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction December 2011
A case report on the efficacy of vigabatrin analogue (1 S , 3 S )-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms January 2016
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 S ,3 S )-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115) February 2015
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase October 1962
Simple, Direct, and Informative Method for the Assessment of CYP2C19 Enzyme Inactivation Kinetics December 2010
Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5′-Phosphate, and [2Fe-2S] Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin October 2003
13 C and 15 N Kinetic Isotope Effects on the Reaction of Aspartate Aminotransferase and the Tyrosine-225 to Phenylalanine Mutant May 2000
2 H, 13 C, and 15 N Kinetic Isotope Effects on the Reaction of the Ammonia-Rescued K258A Mutant of Aspartate Aminotransferase June 2003
Controlling reaction specificity in pyridoxal phosphate enzymes November 2011
Mechanism of action of aspartate aminotransferase proposed on the basis of its spatial structure April 1984
Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy April 1993
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase June 2015
hERG potassium channels and cardiac arrhythmia March 2006
Cytochrome P450 and Chemical Toxicology January 2008
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity April 1997
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States September 2011
The Multiple Active Enzyme Species of γ-Aminobutyric Acid Aminotransferase Are Not Isozymes February 2000
Mechanisms of Inactivation of γ-Aminobutyric Acid Aminotransferase by 4-Amino-5-fluoro-5-hexenoic Acid January 1996
Soluble γ-Aminobutyric-Glutamic Transaminase from Pseudomonas fluorescens April 1959
New substrates and inhibitors of γ-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: Design, synthesis, and biological activity March 2006
Two continuous coupled assays for ornithine-δ-aminotransferase September 2013
Imaging dopamine release with Positron Emission Tomography (PET) and 11C-raclopride in freely moving animals July 2008
Data processing and analysis with the autoPROC toolbox March 2011
How good are my data and what is the resolution? June 2013
PHENIX : building new software for automated crystallographic structure determination October 2002
Coot model-building tools for molecular graphics November 2004
UCSF Chimera?A visualization system for exploratory research and analysis January 2004
H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations May 2012
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility December 2009
A Hybrid QM/MM Simulation Study of Intramolecular Proton Transfer in the Pyridoxal 5′-Phosphate in the Active Site of Transaminase: Influence of Active Site Interaction on Proton Transfer September 2014
Automatic atom type and bond type perception in molecular mechanical calculations October 2006
ACPYPE - AnteChamber PYthon Parser interfacE January 2012
Parameters for molecular dynamics simulations of iron-sulfur proteins April 2013
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit February 2013
Decreasing the Basicity of the Active Site Base, Lys-258, of Escherichia coli Aspartate Aminotransferase by Replacement with .gamma.-thialysine March 1995
Principal component analysis January 2014